Niaspan

In the US, Niaspan (niacin systemic) is a member of the following drug classes: miscellaneous antihyperlipidemic agents, vitamins and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

• Niaspan


• Niaspan Controlled-Release Tablets


• Niaspan ER nicotinic acid

UK matches:

• Niaspan 375 mg , 500mg , 750mg and 1000mg Prolonged-Release Tablets (SPC)
• Niaspan Prolonged-Release Tablets Starter Pack (SPC)

Ingredient matches for Niaspan

Nicotinic Acid

Nicotinic Acid is reported as an ingredient of Niaspan in the following countries:

• Argentina


• Austria


• Canada


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Finland


• France


• Germany


• Hong Kong


• Indonesia


• Ireland


• Luxembourg


• Netherlands


• Norway


• Philippines


• Portugal


• Serbia


• Singapore


• Sweden


• Switzerland


• Thailand


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.